Circularly
polarized luminescent materials play an increasingly
important role in display equipment and optical apparatuses. Herein,
we design and synthesize a kind of luminescent liquid crystalline
polymer with both chirality and aggregation-induced emission groups,
namely, poly(4-cholesterol formate-oxygen-tetraphenylethylene-methacrylate)
(PT-Chol). Polarized light microscopy and X-ray scattering results
show that the polymer forms a layered structure. Because of the existence
of the tetraphenylethylene luminogen, the polymer shows highly efficient
circularly polarized luminescence (CPL) properties with a luminescence
dissymmetry factor (g
lum) of ∼+0.45
after blending a specified amount of 4-cyano-4′-pentyl biphenyl
(5CB), although the pure polymer does not show any CPL behavior in
the solid state. A further experimental result shows that the mixture
of PT-Chol and 5CB can form a chiral nematic liquid crystal (N*-LC)
or smectic C* (Sm C*) phase in low concentration, but the complete
dissolution of PT-Chol in 5CB does not result in the development of
CPL properties. Gradually increasing the concentration of PT-Chol
leads to the development of aggregation-enhanced emission behavior
in the 5CB solution, which results in highly efficient CPL properties
in the Sm C* phase. At the same time, the obtained circularly polarized
luminescent material shows excellent stability, which is conducive
to its applications in optoelectronic devices.
High-efficiency linearly polarized luminescence (LPL) materials are very important for display equipment and optical apparatus. Herein, we construct a free-standing film with wavelength-tunable LPL property through the luminescent material. First,...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.